According to a new report from Intel Market Research, the global Calcitriol market was valued at USD 347 million in 2025 and is projected to reach USD 438 million by 2034, growing at a steady CAGR of 3.5% during the forecast period (2025–2034). This growth is driven by the rising prevalence of chronic kidney disease, expanding therapeutic applications in bone and skin disorders, and...

According to a new report from Intel Market Research, the North America Calcitriol market was valued at USD 139 million in 2025 and is projected to reach USD 189 million by 2034, exhibiting a CAGR of 3.5% during the forecast period. This growth is propelled by the rising prevalence of chronic kidney disease, an aging population in the United States and Canada, and strong reimbursement...

According to a newly published market research report by 24LifeSciences, global secondary hyperparathyroidism treatment market was valued at USD 3.17 billion in 2024 and is projected to reach USD 4.58 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period 20252031. Secondary hyperparathyroidism is an endocrine disorder characterized by excessive...